ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 47 of 2068 for:    Oral Cancer | NIH

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03220009
Recruitment Status : Not yet recruiting
First Posted : July 18, 2017
Last Update Posted : October 17, 2017
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : July 1, 2021
  Estimated Study Completion Date : July 1, 2021